These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Heteroduplex analysis for the three common HFE variants: methodology, reliability and analysis of over 5000 requests for testing. Kingston J; Bowen D; Sweeney M; Lawless S; Jackson H; Worwood M J Clin Pathol; 2007 Nov; 60(11):1244-8. PubMed ID: 17079357 [TBL] [Abstract][Full Text] [Related]
24. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes. Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375 [TBL] [Abstract][Full Text] [Related]
25. High prevalence of the Cys282Tyr HFE mutation facilitates an improved diagnostic service for hereditary haemochromatosis in South Africa. de Villiers JN; Hillerman R; de Jong G; Langenhoven E; Rossouw H; Marx MP; Kotze MJ S Afr Med J; 1999 Mar; 89(3):279-82. PubMed ID: 10226674 [TBL] [Abstract][Full Text] [Related]
26. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Merryweather-Clarke AT; Cadet E; Bomford A; Capron D; Viprakasit V; Miller A; McHugh PJ; Chapman RW; Pointon JJ; Wimhurst VL; Livesey KJ; Tanphaichitr V; Rochette J; Robson KJ Hum Mol Genet; 2003 Sep; 12(17):2241-7. PubMed ID: 12915468 [TBL] [Abstract][Full Text] [Related]
27. Hereditary hemochromatosis: detection of C282Y and H63D mutations in HFE gene by means of guthrie cards in population of Czech Republic. Cimburova M; Putova I; Provaznikova H; Horak J Genet Epidemiol; 2002 Oct; 23(3):260-3. PubMed ID: 12384978 [TBL] [Abstract][Full Text] [Related]
28. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium. Merryweather-Clarke AT; Pointon JJ; Shearman JD; Robson KJ; Jouanolle AM; Mosser A; David V; Le Gall JY; Halsall DJ; Elsey TS; Kelly A; Cox TM; Clare M; Bomford A; Vandwalle JL; Rochette J; Borot N; Coppin H; Roth MP; Ryan E; Crowe J; Totaro A; Gasparini P; Roetto A; Walker AP Nat Genet; 1999 Nov; 23(3):271. PubMed ID: 10545942 [No Abstract] [Full Text] [Related]
29. Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis. Powell LW; Dixon JL; Hewett DG Best Pract Res Clin Haematol; 2005 Jun; 18(2):221-34. PubMed ID: 15737886 [TBL] [Abstract][Full Text] [Related]
30. Genetics of hemochromatosis. Cullen LM; Anderson GJ; Ramm GA; Jazwinska EC; Powell LW Annu Rev Med; 1999; 50():87-98. PubMed ID: 10073265 [TBL] [Abstract][Full Text] [Related]
31. Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Byrnes V; Ryan E; Barrett S; Kenny P; Mayne P; Crowe J Genet Test; 2001; 5(2):127-30. PubMed ID: 11551098 [TBL] [Abstract][Full Text] [Related]
32. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients. Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018 [TBL] [Abstract][Full Text] [Related]
33. Analysis of the HFE gene (C282Y, H63D and S65C) mutations in a general Chinese Han population. Lin A; Yan WH; Xu HH; Zhu M; Zhou MY Tissue Antigens; 2007 Sep; 70(3):252-5. PubMed ID: 17661915 [TBL] [Abstract][Full Text] [Related]
34. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475 [TBL] [Abstract][Full Text] [Related]
35. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload. Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923 [TBL] [Abstract][Full Text] [Related]
36. Review article: the modern diagnosis and management of haemochromatosis. Adams PC Aliment Pharmacol Ther; 2006 Jun; 23(12):1681-91. PubMed ID: 16817911 [TBL] [Abstract][Full Text] [Related]
37. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944 [No Abstract] [Full Text] [Related]
38. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. de Juan D; Reta A; Castiella A; Pozueta J; Prada A; Cuadrado E Eur J Hum Genet; 2001 Dec; 9(12):961-4. PubMed ID: 11840200 [TBL] [Abstract][Full Text] [Related]
39. A primer for predicting risk of disease in HFE-linked hemochromatosis. Adams PC; Walker AP; Acton RT Genet Test; 2001; 5(4):311-6. PubMed ID: 11960576 [TBL] [Abstract][Full Text] [Related]
40. Association of porphyria cutanea tarda with hereditary hemochromatosis. Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]